Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
Fan Liao(Hope Center for Neurological Disorders), David M. Holtzman(Washington University in St. Louis), Paul Lerner(Harvard University), Zachary K. Sweeney(Denali Therapeutics (United States)), Eloïse Hudry(Novartis (Switzerland)), Katheryn B. Lefton(Hope Center for Neurological Disorders), Cheryl E. G. Leyns(Hope Center for Neurological Disorders), Monica Xiong(Sunesis (United States)), Nga Bien‐Ly(Alector (United States)), Jason D. Ulrich(Hope Center for Neurological Disorders), Jennifer A. Getz(Denali Therapeutics (United States)), Kirk R. Henne(Denali Therapeutics (United States)), Bradley T. Hyman(Harvard University), Javier Remolina Serrano(Hope Center for Neurological Disorders), Jennifer Keyser(Hope Center for Neurological Disorders), Ryan J. Watts(Unknown), Mary Beth Finn(Hope Center for Neurological Disorders), Rosa Hoyle(Hope Center for Neurological Disorders), Mark S. Dennis(Denali Therapeutics (United States)), Yin Zhang(Shantou University), Aimin Li(City Of Hope National Medical Center), Hong Jiang(The University of Texas at Arlington), Jing Guo(Qingdao University), Adam P. Silverman(Northwell Health), Gilbert Gallardo(Hope Center for Neurological Disorders), Grace O. Robinson(Hope Center for Neurological Disorders), Patrick M. Sullivan(Veterans Health Administration)
Cited by 186
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k